Evidence map›Paper›PMID 38994983›Full record

ReviewCells2024

Expanding the Neurological Phenotype of Anderson-Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism.

Marialuisa Zedde, Ilaria Romani, Alessandra Scaravilli, Sirio Cocozza, Luigi Trojano, Michele Ragno, Nicola Rifino, Anna Bersano, Simonetta Gerevini, Leonardo Pantoni and 2 more

Abstract readReviewComparative Study
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marialuisa ZeddeNeurology Unit, Stroke Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123 Reggio Emilia, Italy.ORCID 0000-0001-7530-818X
Ilaria RomaniDepartment of Neurosciences, Psychology, Pharmacology and Child Health, University of Florence, 50139 Firenze, Italy.ORCID 0000-0001-7966-3525
Alessandra ScaravilliDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80133 Napoli, Italy.ORCID 0000-0001-6375-5783
Sirio CocozzaDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", 80133 Napoli, Italy.ORCID 0000-0002-0300-5160
Luigi TrojanoDipartimento di Psicologia, Università della Campania 'Luigi Vanvitelli', viale Ellittico 31, 81100 Caserta, Italy.ORCID 0000-0002-0328-9642
Michele RagnoCentro Medico Salute 23, Via O. Licini 5, 63066 Grottammare (AP), Italy.
Nicola RifinoCerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milano, Italy.ORCID 0000-0002-0423-8759
Anna BersanoCerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milano, Italy.ORCID 0000-0002-2493-628X
Simonetta GereviniHead Diagnostic Dept and Neuroradiology Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0002-2374-194X
Leonardo PantoniNeuroscience Research Center, Department of Biomedical and Clinical Science, University of Milan, 20122 Milano, Italy.ORCID 0000-0001-7357-8530
Franco ValzaniaNeurology Unit, Stroke Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123 Reggio Emilia, Italy.
Rosario PascarellaNeuroradiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42123 Reggio Emilia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anderson-Fabry disease (AFD) is a genetic sphingolipidosis involving virtually the entire body. Among its manifestation, the involvement of the central and peripheral nervous system is frequent. In recent decades, it has become evident that, besides cerebrovascular damage, a pure neuronal phenotype of AFD exists in the central nervous system, which is supported by clinical, pathological, and neuroimaging data. This neurodegenerative phenotype is often clinically characterized by an extrapyramidal component similar to the one seen in prodromal Parkinson's disease (PD). We analyzed the biological, clinical pathological, and neuroimaging data supporting this phenotype recently proposed in the literature. Moreover, we compared the neurodegenerative PD phenotype of AFD with a classical monogenic vascular disease responsible for vascular parkinsonism and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). A substantial difference in the clinical and neuroimaging features of neurodegenerative and vascular parkinsonism phenotypes emerged, with AFD being potentially responsible for both forms of the extrapyramidal involvement, and CADASIL mainly associated with the vascular subtype. The available studies share some limitations regarding both patients' information and neurological and genetic investigations. Further studies are needed to clarify the potential association between AFD and extrapyramidal manifestations.

Indexed as

Fabry DiseasePhenotypeCADASILHumansParkinsonian Disordersadvanced MRIAnderson–Fabry diseaseCADASILcerebrovascular diseasemicrobleedsMRIneurodegenerationParkinson’s diseasestrokeWMHs

Identifiers

PMID38994983
PMCPMC11240674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.